A smartphone app, combined with wearable technology, will allow doctors to remotely monitor patients with conditions that limit their ability to voluntarily move their muscles. The app, known as 'aparito', uses a motion-tracking writsband to record the movements of patients with ataxia, and other related ambulatory conditions.
The prospect of widespread access to a life-changing drug for children with a rare muscular disorder is a step closer today after the United States Food and Drug Administration (FDA) granted accelerated approval for a new medication.
NICE have published final guidance recommending ataluren for the treatment of Duchenne Muscular Dystrophy (DMD) caused by a nonsense mutation, in children aged 5 years and over who are able to walk.
The Mildred Creak Unit is for children and young people with mental health problems. Sam Gardiner, a Senior Staff Nurse, shares how the ward helps the people who stay there.
The Zayed Centre for Research into Rare Disease in Children (ZCR) is currently under construction in Guildford Street. Importantly this will include a dedicated facility comprising seven ‘cleanrooms’ where gene and cell therapy medicinal products can be made to treat children compassionately or on a clinical trial.
BRC-supported researcher Dr Kevin Mills has been awarded funding from the NIHR to investigate the regenerative ability of the liver following acute liver failure (ALF). If successful, the team hope that their research will lead to a novel therapy that could buy patients enough time to allow their livers to regenerate naturally, avoiding the need for liver transplants
A collection of century old tumour samples held at Great Ormond Street Hospital (GOSH) has helped shed light on the genetic mutations that cause some of the rarest childhood cancers.
Dr Gwynneth Down is a Consultant Family Psychotherapist. She is the Head of Family Psychotherapy across the Department of Child and Adolescent Mental Health and Psychosocial Services.
A new protein that appears to play a role in mitochondrial disease – a rare condition where a lack of energy in cells means that they can’t function properly – could prove to be important in conditions such as Alzheimer’s, Parkinson’s and Huntington’s diseases.
This morning, the Chancellor of the Exchequer George Osborne visited Great Ormond Street Hospital (GOSH) to announce a new £800 million boost to biomedical research through the National Institute for Health Research (NIHR).
Sir Michael Rake, currently Chairman of the BT Group plc, has been appointed as the new Chairman of Great Ormond Street Hospital for Children NHS Foundation Trust and will take up the position in November 2017.
The Cardiothoracic Unit at Great Ormond Street Hospital (GOSH) is responsible for all aspects of the diagnosis, management and treatment of heart conditions in infants and adolescents.
National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) BRC (Biomedical Research Centre) researchers, working in collaboration with the BRC at NIHR Queen Square Dementia and the Wolfson Biomarker Dementia consortium at Institute of Neurology (IoN), have developed a new test to diagnose different types of dementia, which they hope will allow for more reliable and accurate diagnosis of the neurodegenerative conditions of Lewy Body Dementia and Alzheimer’s disease.
The Clinical Nurse Specialist for Adolescent Medicine is available to all young people on the wards aged 11 years or over, and parents and health professionals involved in their care.
CFS/ME outpatient programme
The Great Ormond Street Hospital Chronic Fatigue Syndrome/Myalgic...
Tanya and Alan found out their daughter, Sandra, had a life-threatening heart condition while Tanya was pregnant. Here, they tell their story about what the diagnosis meant to them and their family.
